Evaluating the antimicrobial efficacy of long-lasting hand sanitizers on skin

Autor: Duggan, K. ^{a, †}, Bentley, K. ^{b, †}, Stanton, R.J. ^b, Maillard, J-Y. ^{a, ∗}

Publikováno v: In Journal of Hospital Infection November 2023 141:107-111

Assessment of the thermal outcome during steam-pulse ablation for sheep tissue

Autor: Anzai, Hitomi ^{a, ⁎}, Stämpfli, Rolf ^b, Wang-Leandro, Adriano ^c, Boesel, Luciano F. ^b, Kemp, Shelley ^b, Rossi, Rene M. ^b, Karol, Agnieszka A. ^d, Ohta, Makoto ^a, Richter, Henning ^c

Publikováno v: In Thermal Science and Engineering Progress 1 October 2021 25

DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA

Autor: Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, Jaime Pérez de Oteyza, Susana Vives, Belen Vidriales, Pilar Herrera, Juan Antonio Vera, Aurelio López Martínez, Adolfo De la Fuente, María Lourdes Amador, José Ángel Hernández-Rivas, María Ángeles Fernández, Carlos Javier Cerveró, Daniel Morillo, Pilar Hernández Campo, Julián Gorrochategui, Daniel Primo, José Luis Rojas, Margarita Guenova, Joan Ballesteros, Miguel Ángel Sanz, Pau Montesinos

Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1, Pp e2019016-e2019016 (2019)

BACKGROUND: Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has been widely studied in multiple clinical trials showing similar complete remissio

Externí odkaz: https://doaj.org/article/81b4fa5b2a224f32948fabdc5eced125

Evaluation of the bactericidal efficacy of three different alcohol hand rubs against clinical isolates of Staphylococcus aureus using an ex vivo carrier test

Autor: Cheeseman, K.E. ^a, Denyer, S.P. ^a, Hosein, I.K. ^b, Williams, G.J. ^a, Maillard, J.-Y. ^{a, ∗}

Publikováno v: In Journal of Hospital Infection 2011 77(1):21-24

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

Autor: Megías-Vericat, Juan Eduardo, Martínez-Cuadrón, David, López, Joaquín Martínez, Bergua, Juan Miguel, Tormo, Mar, Serrano, Josefina, González, Ataulfo, de Oteyza, Jaime Pérez, Vives Polo, Susana, Vidriales, Belén, Herrera, Pilar, Vera, Juan Antonio, Martínez, Aurelio López, de la Fuente, Adolfo, Amador, Ma Lourdes, Hernández-Rivas, José-Ángel, Fernández, Ma Ángeles, Cerveró, Carlos Javier, Morillo, Daniel, Campo, Pilar Hernández, Gorrochategui, Julián, Primo, Daniel, Rojas, José Luis, Guenova, Margarita, Ballesteros, Joan, Sanz, Miguel, Montesinos, Pau, Universitat Autònoma de Barcelona

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean journal of hematology and infectious diseases
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1, Pp e2019016-e2019016 (2019)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA

BACKGROUND: Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has been widely studied in multiple clinical trials showing similar complete remissio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b9eeb4450038202501e3316b86d872c
https://ddd.uab.cat/record/226388